Cardiovascular Outcomes of Insulin Degludec Versus Insulin Glargine in Trial-Eligible and Ineligible Populations: A DEVOTE-Inspired Target Trial Emulation Using the Swedish National Diabetes Register
Diabetes Obes Metab. 2026 Oct 19. doi: 10.1111/dom.71429. Online ahead of print.ABSTRACTAIMS: To compare cardiovascular outcomes associated with the initiation of insulin degludec versus insulin glargine using a target trial emulation approach in nationwide real-world data.MATERIALS AND METHODS: We

